Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC) Trading Up 0.3% – Here’s Why

Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC)’s stock price rose 0.3% during mid-day trading on Wednesday . The stock traded as high as $10.60 and last traded at $10.60. Approximately 1,053 shares were traded during trading, a decline of 98% from the average daily volume of 58,164 shares. The stock had previously closed at $10.57.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Oaktree Acquisition Corp. III Life Sciences in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

Oaktree Acquisition Corp. III Life Sciences Stock Performance

The firm’s 50 day moving average is $10.58 and its 200 day moving average is $10.51.

Institutional Investors Weigh In On Oaktree Acquisition Corp. III Life Sciences

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Driehaus Capital Management LLC bought a new stake in Oaktree Acquisition Corp. III Life Sciences during the first quarter valued at $9,180,000. Lighthouse Investment Partners LLC increased its stake in Oaktree Acquisition Corp. III Life Sciences by 88.9% in the 2nd quarter. Lighthouse Investment Partners LLC now owns 850,000 shares of the company’s stock worth $8,882,000 after acquiring an additional 400,000 shares during the last quarter. Linden Advisors LP purchased a new stake in shares of Oaktree Acquisition Corp. III Life Sciences in the 1st quarter valued at about $6,120,000. Goldman Sachs Group Inc. bought a new stake in shares of Oaktree Acquisition Corp. III Life Sciences during the 1st quarter valued at about $5,417,000. Finally, Moore Capital Management LP purchased a new position in shares of Oaktree Acquisition Corp. III Life Sciences during the second quarter worth about $5,502,000.

Oaktree Acquisition Corp. III Life Sciences Company Profile

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.